Takasawa Kenji, Kano Rui, Maruyama Haruhiko, Hasegawa Atsuhiko, Kamata Hiroshi
Department of Pathobiology, Nihon University School of Veterinary Medicine, 1866 Kameino, Fujisawa, Kanagawa 252-0880, Japan.
Vet Immunol Immunopathol. 2011 Sep 15;143(1-2):167-9. doi: 10.1016/j.vetimm.2011.06.024. Epub 2011 Jun 15.
Lipid A, the active component of lipopolysaccharide (LPS), exists in the outer membrane of Gram-negative bacteria and binds to the Toll-like receptor 4 (TLR4) and MD-2 complex. On the other hand, the synthetic precursor of Escherichia coli lipid A, tetraacylated lipid IVa, is an agonist for TLR4 and MD-2 complex in murine, equine and feline cells but is an antagonist for lipid A in human cells. The aim of the study was to examine the function of canine Toll-like receptor 4 (TLR4) and MD-2 complex on canine blood mononuclear cells (BMC), by analyzing lipid A- or lipid IVa-induction of TNF-α production from these cells in order to understand canine innate immune system. After 5-h culture of canine BMC with lipid A (lipid A culture) or lipid IVa (lipid IVa culture), the TNF-α, as determined by ELISA, had increased in the supernatants of the lipid A cultures in a dose-dependent manner, whereas the TNF-α was undetectable in supernatant of lipid IVa-treated cultures. The TNF-α was statistically significantly different between the lipid A and lipid IVa cultures (100 and 1000 ng/ml). TNF-α production from canine BMC was inhibited, in a lipid IVa-dose-dependent manner, when the BMC were pre-cultured with lipid IVa for 60 min and then cultured with lipid A for 5h, while in control BMC cultures production if TNF-α was unchanged. These results indicate that the TNF-α production stimulated by lipid A was competed out by pre-exposing the BMC to lipid IVa. Thus, lipid A is an agonist for TNF-α production in canine BMC, whereas lipid IVa appears to be an antagonist against this lipid A stimulation of canine BMC.
脂多糖(LPS)的活性成分脂多糖A存在于革兰氏阴性菌的外膜中,并与Toll样受体4(TLR4)和MD-2复合物结合。另一方面,大肠杆菌脂多糖A的合成前体四酰化脂IVa在鼠、马和猫细胞中是TLR4和MD-2复合物的激动剂,但在人细胞中是脂多糖A的拮抗剂。本研究的目的是通过分析脂多糖A或脂IVa诱导犬血液单核细胞(BMC)产生肿瘤坏死因子-α(TNF-α),来研究犬Toll样受体4(TLR4)和MD-2复合物在犬BMC上的功能,以了解犬的先天免疫系统。用脂多糖A(脂多糖A培养)或脂IVa(脂IVa培养)对犬BMC进行5小时培养后,通过ELISA测定,脂多糖A培养上清液中的TNF-α呈剂量依赖性增加,而脂IVa处理培养上清液中未检测到TNF-α。脂多糖A培养和脂IVa培养之间的TNF-α在统计学上有显著差异(100和1000 ng/ml)。当BMC先用脂IVa预培养60分钟,然后用脂多糖A培养5小时时,犬BMC产生的TNF-α以脂IVa剂量依赖性方式受到抑制,而在对照BMC培养中TNF-α的产生则没有变化。这些结果表明,预先将BMC暴露于脂IVa可竞争掉脂多糖A刺激产生的TNF-α。因此,脂多糖A是犬BMC中TNF-α产生的激动剂,而脂IVa似乎是犬BMC对这种脂多糖A刺激的拮抗剂。